TG Therapeutics Secures $500M to Advance BRIUMVI in Relapsing Multiple Sclerosis
Biotech
Lung Organoids Offer a Revolutionary Path to Transform Drug Testing and Cancer Therapies
Merck Expands US Bio Manufacturing with $1B Wilmington Facility for KEYTRUDA
FDA Approves First Targeted Therapy for IDH-Mutant Glioma with Companion Diagnostic
Targeting NBR1: New Biomarker Could Predict Immunotherapy Success in Liver Cancer
Merlin Molecular Test Offers Hope for Melanoma by Reducing Unnecessary Surgeries
New Bioengineering Strategy Promises Treatment for Ulcerative Colitis and Cancer
Castle's Innovative Gene Expression Tests Transform Clinical Decisions for Skin Cancer
New Era in Biotech: Revolutionary Artificial Cells Could Mimic Life and Deliver Drugs
Lexogen Unveils LUTHOR HD: A New Horizon in Single-Cell Transcriptomic Analysis
New Discovery: Are Cell Division Remnants the Hidden Facilitators of Cancer Spread?
Stanford Researchers Discover Anti-Aging Enzyme and Drug Candidate
MIT Researchers Discover Programmable DNA-Cutters in Snails
Early Detection of Drug Resistance in Cancer Patients Possible with Parithera
Newly Discovered Insulin Nanoclusters Could Transform Diabetes Treatment
Modified mRNA Therapy Promises to Repair Heart Damage After Attack
New ALS Treatment on the Horizon: 'Velcro-like' Protein Molecule Identified
New Discovery Shows How Gamma Delta T Cells Can Destroy Cancer
MicroRNA-Based Gene Therapy, Holds Promise in Battle Against Liver Cancer
Subscribe for the latest news and events
Most Popular
Improving Everolimus Safety in Oncology: Missed Opportunities in Risk Minimization
FDA Approves Wegovy to Reduce Risk of Heart Problems in Obese Adults
Targeting the ‘Don’t Eat Me’ Signal: The Future of Macrophage Checkpoint Inhibitors
A New Era in Liver Disease: FDA Approves First Medication 'Rezdiffra' for NASH
Zongertinib Gains FDA Accelerated Approval for HER2+ NSCLC with 75% ORR
Exploring the Transformative Power of AI in Drug Discovery: A report by S&P Global
FDA Grants Accelerated Approval to Semaglutide for MASH with Liver Fibrosis
NETTER-2 Trial: Lutathera Cuts Risk of Death by 72% in Neuroendocrine Tumor Treatment
EpCAM-Targeting ADC CX-2051 Shows Promising Efficacy in Advanced Colorectal Cancer
Bayer Poised for Landmark Year with Blockbuster Treatment Advances Across Key Diseases
NEJM Study Confirms Low-Dose Aspirin Halves Recurrence in Colorectal Cancer
Transformative One-Time Gene Therapy: FDA Approves Pfizer's BEQVEZ, for Hemophilia B
FDA Approves Groundbreaking CAR T Cell Therapy, Abecma, for Multiple Myeloma
New Horizon in Food Allergy Treatment: FDA Approves Xolair for All Ages
FDA Approves Carvykti as Targeted CAR-T Cell Therapy for Multiple Myeloma
